HAXBio
Sign In Join HAXBio
PEPTIDE DATABASE

Semaglutide

Ozempic; Wegovy; Rybelsus

A long-acting GLP-1 receptor agonist used clinically for specific metabolic indications and extensively studied in glucose regulation and body-weight management.

GLP-1 receptor agonist Established clinical compound Approved prescription drug for specific indications in multiple jurisdictions
COMPOUND DATA

Molecular Information

Classification GLP-1 receptor agonist
Molecular Weight Not available
Molecular Formula Not available
Research Status Established clinical compound
BIOLOGICAL ATLAS

Systems Associated With Semaglutide

Brain & CNS

Approved / Established
Established pharmacological pathway

GLP-1 receptor agonist with extensive clinical research across metabolic and glucose-regulatory physiology.

Cardiovascular

Approved / Established
Established pharmacological pathway

GLP-1 receptor agonist with extensive clinical research across metabolic and glucose-regulatory physiology.

Gastrointestinal

Approved / Established
Established pharmacological pathway

GLP-1 receptor agonist with extensive clinical research across metabolic and glucose-regulatory physiology.

Liver

Approved / Established
Established pharmacological pathway

GLP-1 receptor agonist with extensive clinical research across metabolic and glucose-regulatory physiology.

Pancreas & Glucose

Approved / Established
Established pharmacological pathway

GLP-1 receptor agonist with extensive clinical research across metabolic and glucose-regulatory physiology.

Metabolic

Approved / Established
Established pharmacological pathway

GLP-1 receptor agonist with extensive clinical research across metabolic and glucose-regulatory physiology.

Adipose Tissue

Approved / Established
Established pharmacological pathway

GLP-1 receptor agonist with extensive clinical research across metabolic and glucose-regulatory physiology.

Endocrine & Hormonal

Approved / Established
Established pharmacological pathway

GLP-1 receptor agonist with extensive clinical research across metabolic and glucose-regulatory physiology.

STATUS

Regulatory Information

Approved prescription drug for specific indications in multiple jurisdictions

Regulatory status can vary by jurisdiction and may change over time.

HAXBIO COMMUNITY

Semaglutide Discussions & News

Side Effects

Semaglutide

Nausea hit day 3 on semaglutide—is this normal?

@rider.604 · 1 month ago
News

Semaglutide

The GLP-1 shortage news is harder to follow than it should be. I keep seeing updates about semaglutide and tirzepatide coming off shortage lists,...

@justandy8 · 1 month ago
News

Semaglutide

when the fda started tightening the rules around compounded semaglutide and tirzepatide, a lot of people reduced it to “big pharma protecting...

@roadwarrior851 · 1 month ago
Results

Semaglutide

Fasting glucose dropped 18 mg/dL on semaglutide—did appetite change before weight?

@dadnick · 1 month ago
New Peptides

Semaglutide

I keep seeing oral GLP-1 peptides described as the next big step, but how much of that is actually new chemistry versus just better absorption...

@runninglate34 · 1 month ago
Peptide Science

Semaglutide

Compared with regular small-molecule meds, peptides seem almost impossible to take by mouth, yet oral semaglutide exists. Is the main problem...

@eastcoast2 · 1 month ago
Side Effects

Semaglutide

How are people distinguishing the expected GLP-1 side effects from a dose that is simply too high? With semaglutide or tirzepatide, mild nausea...

@pizzadriver · 1 month ago
Results

Semaglutide

who said faster semaglutide weight loss means better results? my muscle mass disagrees.

@littlemoose · 1 month ago

HaxBio provides information for educational and research purposes. Information on this page should not be interpreted as medical advice.